SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-328948
Filing Date
2021-11-15
Accepted
2021-11-15 07:42:05
Documents
13
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d243802d8k.htm   iXBRL 8-K 25579
2 EX-99.1 d243802dex991.htm EX-99.1 48008
  Complete submission text file 0001193125-21-328948.txt   209651

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20211115.xsd EX-101.SCH 2880
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20211115_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20211115_pre.xml EX-101.PRE 11852
6 EXTRACTED XBRL INSTANCE DOCUMENT d243802d8k_htm.xml XML 3520
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 211406370
SIC: 2834 Pharmaceutical Preparations